id: minds_based_aws_protocol_implementation_to_benzodiazepine_exposure
name: MINDS-Based Alcohol Withdrawal Syndrome Protocol Implementation â†’ Total Benzodiazepine
  Exposure
from_node:
  node_id: minds_based_aws_protocol_implementation
  node_name: MINDS-Based Alcohol Withdrawal Syndrome Protocol Implementation
to_node:
  node_id: benzodiazepine_exposure
  node_name: Total Benzodiazepine Exposure
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Implementation of standardized MINDS-based protocol (SDAWP) provides systematic
  symptom assessment framework for alcohol withdrawal syndrome'
- 'Step 2: Symptom-triggered therapy approach using revised MINDS index enables more
  precise titration of benzodiazepine administration based on objective withdrawal
  severity'
- 'Step 3: Standardized assessment reduces unnecessary or excessive benzodiazepine
  dosing while maintaining therapeutic efficacy'
- 'Step 4: Lower cumulative benzodiazepine exposure achieved while maintaining patient
  safety'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Kevin M Krcmarik et al. 2023. "Assessment of a modified MINDS-based
    protocol for management of alcohol withdrawal syndrome on an inpatient medical
    service.." *Pharmacotherapy*. https://doi.org/10.1002/phar.2855
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.738553'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: inpatient_medical_ward_setting
  direction: strengthens
  strength: moderate
  description: Protocol implemented outside ICU setting demonstrates effectiveness
    in general medical ward with potentially less intensive monitoring capabilities
